Abstract:Lignan, a beneficial constituent of Flaxseed ( Linum usitatissimum L.) showed great interest in researchers because of its multiple functional properties. Nonetheless, a challenge arises due to the glycosidic structure of lignans, which the gut epithelium cannot readily absorb. Therefore, we screened 18 strains of Lactiplantibacillus plantarum , Lacticaseibacillus casei , Lactobacillus acidophilus , Lacticaseibacillus rhamnosus, Pediococcus pentosaceus, Pediococcus acidilactici , and Enterococcus durans to remove glycosides from flaxseed lignan extract enzymatically. Among our findings, Lactiplantibacillus plantarum SCB0151 showed the highest activity of β-glucosidase (8.91 ± 0.04 U/mL) and higher transformed efficiency of Secoisolariciresinol (SECO) (8.21 ± 0.13%). The conversion rate of Secoisolariciresinol diglucoside (SDG) and the generation rate of SECO was 58.30 ± 3.78% and 32.13 ± 2.78%, respectively, under the optimized conditions. According to the LC-HRMSMS analysis, SECO (68.55 ± 6.57 μM), Ferulic acid (FA) (32.12 ± 2.50 μM), and Coumaric acid (CA) (79.60 ± 6.21 μM) were identified in the biotransformation products (TP) of flaxseed lignan extract. Results revealed that the TP exhibited a more pronounced anti-inflammatory effect than the flaxseed lignan extract. SECO, FA, and CA demonstrated a more inhibitory effect on NO than that of SDG. The expression of iNOS and COX-2 was significantly suppressed by TP treatment in LPS-induced Raw264.7 cells. The secretion of IL-6, IL-2, and IL-1β decreased by 87.09 ± 0.99%, 45.40 ± 0.87%, and 53.18 ± 0.83%, respectively, at 60 μg/mL of TP treatment. Given these data, the bioavailability of flaxseed lignan extract and its anti-inflammatory effect were significantly enhanced by Lactiplantibacillus plantarum SCB0151, which provided a novel approach to commercializing flaxseed lignan extract for functional food.

Bioavailability and Pharmacokinetic Parameters of a Formulation Containing Secoisolariciresinol Diglucoside–Rich Extract

Isolation, characterization and antihyperlipidemic activity of secoisolariciresinol diglucoside in poloxamer-407-induced experimental hyperlipidemia

Separation and Determination of Secoisolariciresinol Diglucoside Oligomers and Their Hydrolysates in the Flaxseed Extract by High-Performance Liquid Chromatography.

Determination Of The Lignan Secoisolariciresinol Diglucoside From Flaxseed (Linum Usitatissimum L.) By Hplc

Availability of bioactive flax lignan from foods and supplements

Effects of the flaxseed lignans secoisolariciresinol diglucoside and its aglycone on serum and hepatic lipids in hyperlipidaemic rats

Ultrasonic-Assisted Aqueous Two-Phase Extraction Combined with Macroporous Resin Enrichment of Lignans from Flaxseed Meal and Their Antioxidant Activities.

Potential protective properties of flax lignan secoisolariciresinol diglucoside

The fate of flaxseed-lignans after oral administration: A comprehensive review on its bioavailability, pharmacokinetics, and food design strategies for optimal application

A comparative study on flaxseed lignan biotransformation through resting cell catalysis and microbial fermentation by β-glucosidase production Lactiplantibacillus plantarum

Dynamic Changes of Phytochemical Profiles Identified Key Points of Flaxseed Capsule Maturation for Lignan Accumulation

Anti-inflammatory effect of lignans from flaxseed after fermentation by lactiplantibacillus plantarum SCB0151 in vitro

High-yield production of secoisolariciresinol diglucoside from flaxseed hull by extraction with alcoholic ammonium hydroxide and chromatography on microporous resin

Structural Modifications of a Flaxseed Lignan in Pursuit of Higher Liposolubility: Evaluation of the Antioxidant and Permeability Properties of the Resulting Derivatives

Distribution, biosynthesis and therapeutic potential of lignans

Quantitative determination of the group of flavonoids and saponins from the extracts of the seeds of Glinus lotoides and tablet formulation thereof by high-performance liquid chromatography

Hydrolysis Kinetics of Secoisolariciresinol Diglucoside Oligomers from Flaxseed

Simultaneous Quantification of Secoisolariciresinol Diglucoside and Cyanogenic Glycosides in Flaxseed Products by Various Processing Methods

Production of Secoisolariciresinol from Defatted Flaxseed by Bacterial Biotransformation

Oral Bioavailability Evaluation of Celastrol-Encapsulated Silk Fibroin Nanoparticles Using an Optimized LC-MS/MS Method

Bioconversion of lignans in flaxseed cake by fermented tofu microbiota and isolation of Enterococcus faecium strain ZB26 responsible for converting secoisolariciresinol diglucoside to enterodiol